Media outlets starting with C
-
CCancer Currents: An NCI Cancer Research Blog
Cancer Currents: An NCI Cancer Research Blog highlights Cancer Treatment and Research, Medical News and Developments, and more. The fundamentals of working with bloggers are the same as with traditional journalists at traditional media outlets: respect their schedules; take time to read their material to learn their interests; and only contact them if/when they want to be contacted. You will also find that if a blogger is a journalist for another outlet(s), Cision tracks their contact preferences there as well. The outlet offers RSS (Really Simple Syndication).
-
CCancer Dietitian
Cancer Dietitian is a health blog that offers nutrition guidelines, personal health tips, and cancer information. The fundamentals of working with bloggers are the same as with traditional journalists at traditional media outlets: respect their schedules; take time to read their material to learn their interests; and only contact them if/when they want to be contacted. You will also find that if a blogger is a journalist for another outlet(s), Cision tracks their contact preferences there as well. The outlet offers RSS (Really Simple Syndication).
-
CCancer Discovery
Publishes high impact articles from basic to clinical research and comprehensive news and information related to cancer research. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to epidemiologic studies. The journal also publishes News and Research Watch sections. The outlet offers RSS (Really Simple Syndication).
-
CCancer Discovery Online
Publishes high impact articles from basic to clinical research and comprehensive news and information related to cancer research. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to epidemiologic studies. The journal also publishes News and Research Watch sections. The outlet offers RSS (Really Simple Syndication).
-
CCancer Epidemiology
Impact Factor: 2.644 (Source: 2016 Journal Citation Reports, Thomson Reuters) Circulation: The Publisher does not disclose the circulation. Frequency: Bi Monthly Aims of the journal: Cancer Epidemiology aims to be the International journal for cancer epidemiology, detection and prevention is dedicated to increasing understanding about cancer causes, prevention and control. The scope of the journal embraces all aspects of cancer epidemiology including: Descriptive epidemiology and statistics Studies of risk factors for disease initiation, development and prognosis Screening, early detection and accurate diagnosis Prevention and evaluation of interventions Methodological issues and theory Content: The journal publishes original research articles (full length and short reports), systematic reviews and meta-analyses, editorials, commentaries and letters to the editor commenting on previously published research. Manuscript submission: Author guidelines can be viewed here. Online manuscripts submissions can be made here.
-
Cancer Gene Therapy
Publishes the results of laboratory investigations, preclinical studies and clinical trials in the field of gene transfer/gene therapy as applied to cancer research. Consists of original research articles, case reports, preliminary communications, brief descriptions of important innovative developments, review articles, updates on progress in the main field of drug resistance/sensitivity gene therapy, tumor suppressor and anti-oncogene therapy, cytokine/tumor, and immunotherapy, industry perspective, descriptions of the newest technology being developed in the corporate sector, and letters to the editor, and well as brief comments on articles published in the journal.
-
CCancer Genetics
Formerly titled Cancer Genetics and Cytogenetics and targets clinical and experimental oncologists and radiologists. Provides current awareness service and information, experimental and clinical aspects of malignant neoplastic disease, as well as research in cancer immunology, oncogenes, viral and chemical carcinogenesis and cancer chemotherapeutic agents. Also covers cancer research, diagnosis, treatment, epidemiology and prevention and childhood cancer.
-
C
-
CCancer Investigation
Impact Factor: 2.231 (Source: Thomson Reuters, 2016 Journal Citation Reports) Circulation: The Publisher does not disclose the circulation. Frequency: Published 10 times a year Months of Distribution: Vary Aims of the journal: Cancer Investigation is designed to provide workers in both the basic and clinical sciences who need to keep informed about the current state of progress in the cancer field with the broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, and letters to the editor. The journal is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. Content: In addition to presenting original papers, the journal also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic. Editorial contacts: The editorial board can be viewed here. Manuscript submission: See the instructions for submissions here. Other information: Please find advertising information here.
-
CCancer Law Weekly
NewsRX™ is a digital news, publishing technology and IT company and uses an automated article writing and periodical production software platform (Artificial Intelligence Journalist – AIJ) producing 35,000 unique articles weekly and 195 autocreated digital newsweeklies. Artificial Intelligence Journalist™ (“AIJ”) and Artificial Intelligence Editor™ (“AIE”), is a proprietary software technology which automates every aspect of publishing, from writing and editing to distribution and analytics.